Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

439 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ESTRO-ACROP guideline "target delineation of glioblastomas".
Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C. Niyazi M, et al. Among authors: grosu al. Radiother Oncol. 2016 Jan;118(1):35-42. doi: 10.1016/j.radonc.2015.12.003. Epub 2016 Jan 6. Radiother Oncol. 2016. PMID: 26777122
Evaluation of intensity modulated radiation therapy dose painting for localized prostate cancer using 68Ga-HBED-CC PSMA-PET/CT: A planning study based on histopathology reference.
Zamboglou C, Sachpazidis I, Koubar K, Drendel V, Wiehle R, Kirste S, Mix M, Schiller F, Mavroidis P, Meyer PT, Werner M, Grosu AL, Baltas D. Zamboglou C, et al. Among authors: grosu al. Radiother Oncol. 2017 Jun;123(3):472-477. doi: 10.1016/j.radonc.2017.04.021. Epub 2017 May 9. Radiother Oncol. 2017. PMID: 28499607
Neuroimaging for Radiation Therapy of Brain Tumors.
Popp I, Weber WA, Combs SE, Yuh WTC, Grosu AL. Popp I, et al. Among authors: grosu al. Top Magn Reson Imaging. 2019 Apr;28(2):63-71. doi: 10.1097/RMR.0000000000000198. Top Magn Reson Imaging. 2019. PMID: 31022049 Review.
[68Ga-]PSMA-11 PET/CT and multiparametric MRI for gross tumor volume delineation in a slice by slice analysis with whole mount histopathology as a reference standard - Implications for focal radiotherapy planning in primary prostate cancer.
Bettermann AS, Zamboglou C, Kiefer S, Jilg CA, Spohn S, Kranz-Rudolph J, Fassbender TF, Bronsert P, Nicolay NH, Gratzke C, Bock M, Ruf J, Benndorf M, Grosu AL. Bettermann AS, et al. Among authors: grosu al. Radiother Oncol. 2019 Dec;141:214-219. doi: 10.1016/j.radonc.2019.07.005. Epub 2019 Aug 17. Radiother Oncol. 2019. PMID: 31431366
Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.
Klement RJ, Sonke JJ, Allgäuer M, Andratschke N, Appold S, Belderbos J, Belka C, Dieckmann K, Eich HT, Flentje M, Grills I, Eble M, Hope A, Grosu AL, Semrau S, Sweeney RA, Hörner-Rieber J, Werner-Wasik M, Engenhart-Cabillic R, Ye H, Guckenberger M. Klement RJ, et al. Among authors: grosu al. Radiother Oncol. 2020 Jan;142:210-216. doi: 10.1016/j.radonc.2019.07.008. Epub 2019 Aug 17. Radiother Oncol. 2020. PMID: 31431371
Validation of different PSMA-PET/CT-based contouring techniques for intraprostatic tumor definition using histopathology as standard of reference.
Zamboglou C, Fassbender TF, Steffan L, Schiller F, Fechter T, Carles M, Kiefer S, Rischke HC, Reichel K, Schmidt-Hegemann NS, Ilhan H, Chirindel AF, Nicolas G, Henkenberens C, Derlin T, Bronsert P, Mavroidis P, Chen RC, Meyer PT, Ruf J, Grosu AL. Zamboglou C, et al. Among authors: grosu al. Radiother Oncol. 2019 Dec;141:208-213. doi: 10.1016/j.radonc.2019.07.002. Epub 2019 Aug 17. Radiother Oncol. 2019. PMID: 31431386
Prostate-specific Membrane Antigen Positron Emission Tomography-detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation.
Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Vogel MME, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Eiber M, Mix M, la Fougère C, Christiansen H, Belka C, Combs SE, Grosu AL, Müller AC, Guckenberger M. Kroeze SGC, et al. Among authors: grosu al. Eur Urol Focus. 2021 Mar;7(2):309-316. doi: 10.1016/j.euf.2019.08.012. Epub 2019 Sep 5. Eur Urol Focus. 2021. PMID: 31495759
Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy.
Vogel MME, Kroeze SGC, Henkenberens C, Schmidt-Hegemann NS, Kirste S, Becker J, Burger IA, Derlin T, Bartenstein P, Mix M, la Fougère C, Eiber M, Christiansen H, Belka C, Grosu AL, Müller AC, Guckenberger M, Combs SE. Vogel MME, et al. Among authors: grosu al. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2328-2338. doi: 10.1007/s00259-020-04760-8. Epub 2020 Mar 16. Eur J Nucl Med Mol Imaging. 2020. PMID: 32179961 Free PMC article.
Correlating Dose Variables with Local Tumor Control in Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer: A Modeling Study on 1500 Individual Treatments.
Klement RJ, Sonke JJ, Allgäuer M, Andratschke N, Appold S, Belderbos J, Belka C, Blanck O, Dieckmann K, Eich HT, Mantel F, Eble M, Hope A, Grosu AL, Nevinny-Stickel M, Semrau S, Sweeney RA, Hörner-Rieber J, Werner-Wasik M, Engenhart-Cabillic R, Ye H, Grills I, Guckenberger M. Klement RJ, et al. Among authors: grosu al. Int J Radiat Oncol Biol Phys. 2020 Jul 1;107(3):579-586. doi: 10.1016/j.ijrobp.2020.03.005. Epub 2020 Mar 15. Int J Radiat Oncol Biol Phys. 2020. PMID: 32188579
Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO/DGMP Working Group Stereotactic Radiotherapy and Radiosurgery.
Guckenberger M, Baus WW, Blanck O, Combs SE, Debus J, Engenhart-Cabillic R, Gauer T, Grosu AL, Schmitt D, Tanadini-Lang S, Moustakis C. Guckenberger M, et al. Among authors: grosu al. Strahlenther Onkol. 2020 May;196(5):417-420. doi: 10.1007/s00066-020-01603-1. Strahlenther Onkol. 2020. PMID: 32211940 Free PMC article. Review.
439 results